300813 TAILIN
- 17.24
- +0.18+1.06%
TAILIN News
TAILIN: Announcement on the Conversion of Convertible Corporate Bonds into Shares in the Second Quarter of 2024.
TAILIN: Zhejiang Tailin Biotech Co., Ltd. entrusted management report for convertible corporate bonds issued to unspecified objects (2023)
TAILIN: 2021, Zhejiang Tailin Biotechnology Co., Ltd. issued convertible corporate bonds on the Growth Enterprise Market to unspecified parties. This report tracks the rating until 2024.
TAILIN: Announcement on the adjustment of Tailin's debt-for-equity conversion price
TAILIN: Announcement on the completion of the election of the Board of Directors for a new term
TAILIN: Legal Opinion of Guo Hao (Hangzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Tailin Biotechnology Co., Ltd.
TAILIN: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
TAILIN: Announcement on the completion of the election of the Board of Supervisors for a new term
TAILIN: Announcement on the appointment of senior management personnel, securities affairs representatives and heads of internal audit departments
Tailin Biotech: Announcement on the Use of Some Idle Funds Raised and Own Funds for Cash Management
Tailin Biotech: Announcement on the election of the board of directors for a new term
Tailin Biotech: Announcement on the 2024 Remuneration Plan for Directors, Supervisors and Senior Management
Tailin Biotech: 2023 Financial Results Report
Tailin Biotech: Announcement on the Company and its wholly-owned subsidiaries applying for comprehensive credit lines from banks
Tailin Biotech: An indicative announcement on the disclosure of the 2023 Annual Report
Tailin Biotech: An indicative announcement on the disclosure of the report for the first quarter of 2024
Tailin Biotech: Announcement on Election of Staff Representative Supervisors for the 4th Board of Supervisors
Tailin Biotech: 2023 Internal Control Self-Assessment Report
Tailin Biotech: Notice on requesting the shareholders' meeting to authorize the board of directors to issue A-shares to specific targets through simple procedures
Tailin Biotech: Report of the Audit Committee on the performance of supervisory duties by accounting firms in 2023
Analysis
Price Target
No Data
